Abstract
We developed highly expressing clade B and AE DNA and envelope protein (Env) vaccines for evaluation in mice and macaques as DNA prime/protein boost regimens. High levels of Env-specific antibodies were induced in mice, albeit with limited neutralizing activity in vitro. A combined clade B and AE regimen induced high titer Env-specific antibody in two pigtail macaques that neutralized several strains of HIV-1. However, upon mucosal challenge with SHIV(SF162P3) no protection from infection was observed. Although the vaccines tested provide a platform for inducing robust humoral immunity, further refinements to broaden coverage against divergent strains and induce mucosal immunity are needed.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
AIDS Vaccines / immunology*
-
Animals
-
Antibodies, Neutralizing / immunology*
-
Female
-
HIV Antibodies / blood
-
HIV Infections / immunology
-
HIV Infections / prevention & control*
-
HIV-1 / immunology*
-
HeLa Cells
-
Humans
-
Immunity, Cellular
-
Immunity, Humoral
-
Macaca nemestrina
-
Male
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred C57BL
-
Neutralization Tests
-
Recombinant Proteins / immunology
-
T-Lymphocytes / immunology
-
Vaccines, DNA / immunology
-
env Gene Products, Human Immunodeficiency Virus / immunology*
Substances
-
AIDS Vaccines
-
Antibodies, Neutralizing
-
HIV Antibodies
-
Recombinant Proteins
-
Vaccines, DNA
-
env Gene Products, Human Immunodeficiency Virus
-
gp140 envelope protein, Human immunodeficiency virus 1